Polycythemia Vera Treatment in India

Released Date: 2026-05-06

Polycythemia Vera Treatment in India


Polycythemia Vera Treatment in India — A Complete Guide for International Patients

Polycythemia Vera (PV) is a rare but serious blood cancer that causes the bone marrow to produce too many red blood cells, making the blood dangerously thick and slow-moving. If you or someone you love has been diagnosed with PV, getting the right treatment quickly is critical. India has emerged as one of the world's most trusted destinations for PV treatment — offering world-class haematology expertise at a fraction of the cost of Western countries.

What is Polycythemia Vera?

Polycythemia Vera is a type of myeloproliferative neoplasm (MPN) — a group of blood cancers originating in the bone marrow. It is driven in approximately 95–98% of cases by a genetic mutation called JAK2 V617F, which causes uncontrolled production of red blood cells, and often white blood cells and platelets as well.

The excess blood cells thicken the blood, significantly raising the risk of dangerous blood clots, strokes, and heart attacks. Without treatment, PV can progress to myelofibrosis (scarring of the bone marrow) or, in some cases, acute leukaemia.

Who is at Risk?

PV is most commonly diagnosed in people over the age of 60, though it can occur at any age. It is slightly more common in men than women. The condition develops slowly, and many patients are diagnosed incidentally through a routine blood test before symptoms become apparent.

Symptoms to Watch For

  • Persistent headaches and dizziness
  • Blurred or double vision
  • Itching, especially after a warm bath or shower (aquagenic pruritus)
  • Redness and burning sensation in the hands and feet (erythromelalgia)
  • Unexplained fatigue and weakness
  • Enlarged spleen causing fullness or discomfort in the left abdomen
  • Excessive sweating and unexpected weight loss
  • Unusual bruising or bleeding

How is Polycythemia Vera Diagnosed?

Diagnosis involves a combination of blood tests, genetic testing and bone marrow biopsy. The three key diagnostic criteria used globally are:

  • Elevated haemoglobin or haematocrit — above normal range for age and gender
  • JAK2 mutation test — positive JAK2 V617F or JAK2 exon 12 mutation
  • Bone marrow biopsy — showing hypercellularity with proliferation of red cell, white cell and platelet precursors
  • Subnormal erythropoietin level — helps differentiate PV from secondary causes of high red cell count

Risk Stratification — How Indian Doctors Plan Your Treatment

Risk CategoryCriteriaTreatment Approach
Low RiskAge below 60, no history of blood clotsPhlebotomy + Low-dose Aspirin
High RiskAge above 60 OR prior blood clot historyAbove + Cytoreductive therapy (Hydroxyurea or Pegylated Interferon-alpha)
Refractory / IntolerantInadequate response to HydroxyureaRuxolitinib or Ropeginterferon

Why Choose India for Polycythemia Vera Treatment?

India offers a compelling combination of medical excellence and affordability for international patients seeking PV treatment.

Expert Haematologists — India's top haematologists are trained at leading institutions in the USA, UK and Europe, and follow the latest international guidelines for PV management published by the European LeukemiaNet and the American Society of Hematology.

Advanced Diagnostics — JAK2 mutation testing, bone marrow biopsy with FISH analysis, flow cytometry and molecular profiling are all available at major Indian hospitals with fast turnaround times.

All Treatment Options Available — From phlebotomy and hydroxyurea to ruxolitinib and ropeginterferon, every treatment approved globally is available in India.

Cost Advantage — The cost of PV treatment in India is 60–80% lower than in the USA, UK or Europe, without any compromise on quality of care or drug authenticity.

No Waiting Lists — Patients can be seen by a senior haematologist within days of arrival, with treatment commencing almost immediately.

How Satyug Healthcare Helps You Access PV Treatment in India

Navigating a rare blood cancer diagnosis in a foreign country can feel overwhelming. Satyug Healthcare specialises in making this journey as smooth and stress-free as possible for international patients.

  • Free Medical Opinion — Share your medical reports with us and we will arrange a free written opinion from a senior haematologist at a JCI or NABH accredited hospital within 24–48 hours.
  • Multiple Doctor Opinions — We believe every patient deserves options. We arrange consultations with two or more leading haematologists so you can choose the doctor and hospital you feel most confident with.
  • Hospital Selection — We are associated with India's top hospitals for blood cancer care including BLK-Max Super Speciality Hospital (New Delhi), Indraprastha Apollo Hospital (New Delhi), Medanta The Medicity (Gurugram), Amrita Hospital (Faridabad) and Fortis Memorial Research Institute (Gurugram).
  • Complete Coordination — From your airport pick-up on arrival to your hotel accommodation, hospital appointments, treatment scheduling and discharge planning — we handle everything so you can focus entirely on your health.
  • Medical Visa Assistance — We provide the official medical visa invitation letter and guide you through the entire visa application process for India.
  • Translation Support — Our team communicates in English, Arabic, Russian, French and other languages to ensure there is never a communication barrier between you and your medical team.
  • Post-Treatment Follow-Up — PV requires long-term monitoring. Even after you return home, we coordinate video consultations between you and your treating haematologist in India, ensuring continuity of care.

Frequently Asked Questions

1. Is Polycythemia Vera curable? PV is currently not considered curable with standard treatments. However, it is very manageable. Most patients with well-controlled PV live for decades with a good quality of life. The only potential cure is allogeneic stem cell transplantation, which is reserved for selected high-risk patients who progress to myelofibrosis.

2. How long does PV treatment take in India? Initial consultation, diagnosis confirmation and treatment initiation typically takes 7–10 days. For patients requiring phlebotomy and oral medications only, treatment can begin almost immediately and continued at home with periodic remote monitoring.

Contact Satyug Healthcare

If you have been diagnosed with Polycythemia Vera and are considering treatment in India, our team is ready to assist you immediately.

📞 +91-8860606766 | +91-9910655125 

Related Blogs

HAPPY PATIENTS

What Our Patients Are Saying

Our Gallery


Request a Call Back

WhatsApp Us